Table 1.
Substrate | Ligand | Kd (μM) | n | ΔH (kJ/mol) | ΔS (J/mol·K) |
---|---|---|---|---|---|
SARS-CoV-2 | |||||
N | Ubl1 | 0.8 ± 0.2 | 1.19 ± 0.02 | −62.5 ± 2.6 | −99.0 |
Ubl1 | N-arm–NTD–LKR | 0.7 ± 0.2 | 0.60 ± 0.02 | −33.7 ± 1.9 | 0.9 |
Ubl1 | NTD–LKR | 0.8 ± 0.2 | 0.64 ± 0.01 | −34.5 ± 1.2 | −2.5 |
Ubl1 | NTD | 17.0 ± 4.2 | 0.73 ± 0.03 | −11.3 ± 1.2 | 52.3 |
Ubl1 | CTD–C-tail | N.D.a | - | - | - |
Ubl1 | NTD R92A | 55.7 ± 16.3 | 0.58 ± 0.11 | −13.3 ± 3.2 | 35.5 |
Ubl1 E26A | NTD | 78.6 ± 25.3 | 0.74 ± 0.04 | −14.1 ± 1.7 | 29.7 |
Ubl1 E95A | NTD | 53.1 ± 18.2 | 0.75 ± 0.08 | −5.2 ± 1.2 | 63.8 |
Ubl1 Y103A | NTD | 57.7 ± 22.4 | 0.57 ± 0.05 | −3.1 ± 0.6 | 70.5 |
Ubl1 D110A | NTD | 50.8 ± 14.3 | 0.64 ± 0.06 | −11.1 ± 0.8 | 44.0 |
SARS-CoV | |||||
N | Ubl1 | 0.8 ± 0.2 | 1.00 ± 0.02 | −55.9 ± 1.6 | −76.2 |
MERS-CoV | |||||
N | Ubl1 | 2.3 ± 0.6 | 0.82 ± 0.02 | 25.5 ± 1.3 | 196.0 |
aN.D.: not determined.